Senate committee hears SB4 ‘right to shop’ proposal to link price transparency with patient incentives

Senator Shelly Hughes, sponsor of Senate Bill 4, told the Senate Health and Social Services Committee on April 20 that the bill would give patients “the right to know, the right to save, and the right to pick” by requiring insurers to make price and provider information available and by sharing savings with consumers who choose lower‑cost, medically necessary options.

The bill’s central mechanism would require insurers to provide cost comparisons by phone and online; when a patient chooses a provider whose charge falls below the benchmark, the savings would be shared. Hughes described a split in the bill’s text: for employer plans the difference would be divided roughly one‑third to the patient, one‑third to the employer and one‑third to the insurer; for individually purchased plans the bill calls for a 50/50 split between patient and insurer. Aaliyah Preston, staff for Sen. Hughes, told the committee health care prices have risen sharply and described SB4’s aim as giving patients an incentive to seek “high value care.”

Why it matters: committee members heard that Alaska’s high health care prices strain family budgets and public plans and that several other states have enacted similar programs. Proponents testified that pairing transparency with a financial incentive increases consumer use of cost information and can pressure high‑price providers to lower rates. Rob Graybill, senior vice president at Xelliss and co‑founder of Smart Shopper, said “member shared savings models are proven to work and patients love them,” and described work his company has done delivering shared‑savings programs and reported savings for other state employee plans. Tim Frost, a pharmacist and senior fellow at the Cicero Institute, said the bill “aligns incentives to transform the transparency from a passive disclosure into an active cost‑saving strategy.”

Opponents’ and regulators’ concerns: Laurie Winghire, director of the Division of Insurance, told the committee that practical and legal limits exist on publishing some pricing data. “They cannot post network rates and not identify necessarily the provider himself or herself,” she said, and noted that insurance companies’ published data typically reflect what the insurer will pay rather than the full set of provider charge data that hospitals or independent providers might post. Winghire said some contract terms and longstanding confidentiality practices around negotiated in‑network payments can complicate publishing per‑provider in‑network amounts and that the division would need to review how the bill’s disclosure requirements interact with current law and contracts.

Implementation questions raised by committee members included how benchmark prices would be calculated (median versus mean), how incentives would apply where rural Alaskans have limited alternative providers, and whether insurers’ existing federal price‑transparency tools would be sufficient to meet the bill’s requirements. Witnesses pointed to federal rules—the Transparency in Coverage regulation and the No Surprises Act—as existing elements that create price‑tool infrastructure, but they said SB4’s role is to tie those tools to a consumer incentive.

Next steps: the committee treated SB4 as an initial hearing with invited testimony, asked technical questions of the sponsor and witnesses, and did not take a vote. Chairs indicated the bill will return for further consideration and additional work on technical definitions (for example, how to compute the benchmark price and how to handle rural/remote access issues).

Ending: Supporters urged the committee to pair transparency with incentives so patients would act on price information; regulators asked for time to resolve how contractual confidentiality and data sources would be handled if the bill requires insurer‑level cost displays.